Amedeo Smart

Free Medical Literature Service


 

Amedeo

Ovarian Neoplasms

  Free Subscription

Articles published in
Int J Gynaecol Obstet
    January 2024
  1. BRENT SE, McGee J, Vicus D, Kim R, et al
    Rates of genetic consultation in high-grade serous ovarian cancer patients in the era of PARP inhibitor therapy: A population-based study.
    Int J Gynaecol Obstet. 2024 Jan 29. doi: 10.1002/ijgo.15391.
    >> Share

    December 2023
  2. DEMISSIE L, Birara M, Tolu LB, Sium AF, et al
    Recurrent ovarian cancer in Africa: Rate and associated factors at a gynecologic oncology treatment center in Ethiopia-A cross-sectional study.
    Int J Gynaecol Obstet. 2023 Dec 26. doi: 10.1002/ijgo.15316.
    >> Share

    November 2023
  3. LUO L, Xu N, Liu Y, Zhong S, et al
    Prognostic factors and novel nomograms for overall survival and cancer specific survival of malignant ovarian cancer patients with bone metastasis: A SEER-based study.
    Int J Gynaecol Obstet. 2023 Nov 27. doi: 10.1002/ijgo.15261.
    >> Share

  4. GAO C, Han Y, Fan X, Dong H, et al
    A case of unilateral sclerosing stromal tumor of the ovary in a postmenopausal female.
    Int J Gynaecol Obstet. 2023 Nov 12. doi: 10.1002/ijgo.15221.
    >> Share

  5. MA X, Xu L, Ma F, Zhang J, et al
    Whole-tumor apparent diffusion coefficient histogram analysis for preoperative risk stratification in endometrial endometrioid adenocarcinoma.
    Int J Gynaecol Obstet. 2023 Nov 4. doi: 10.1002/ijgo.15226.
    >> Share

  6. RATHAT G, Blay L, Bakenga J, Roggen N, et al
    Scarless preventive surgery.
    Int J Gynaecol Obstet. 2023;163:701-702.
    >> Share

    September 2023
  7. EL HAYEK P, Chlala W, Younes K, Ghaname W, et al
    Severe hemoperitoneum from spontaneous rupture of uterine tumor resembling ovarian sex-cord tumor: A very rare case.
    Int J Gynaecol Obstet. 2023 Sep 25. doi: 10.1002/ijgo.15151.
    >> Share

  8. AYHAN A, Tunc M, Akilli H, Haberal N, et al
    Fertility-sparing approach to malignant ovarian germ cell tumors - Oncologic and obstetric outocome: A retrospective study.
    Int J Gynaecol Obstet. 2023 Sep 22. doi: 10.1002/ijgo.15141.
    >> Share

  9. ANDERSON D, Garcia K, Fang W, Duenas-Garcia O, et al
    Feasibility of opportunistic salpingectomy at the time of a vNOTES hysterectomy: A retrospective cohort.
    Int J Gynaecol Obstet. 2023 Sep 3. doi: 10.1002/ijgo.15085.
    >> Share

    July 2023
  10. BORELLA F, Bertero L, Valabrega G, Fucina S, et al
    Searching for prognostic markers for Stage I epithelial ovarian cancer: A role for systemic inflammatory markers.
    Int J Gynaecol Obstet. 2023 Jul 27. doi: 10.1002/ijgo.15014.
    >> Share

  11. LAVECCHIA M, Dubey A, Jimenez W, Reade CJ, et al
    Intraoperative predictors of appendiceal abnormalities in patients with mucinous ovarian neoplasms.
    Int J Gynaecol Obstet. 2023 Jul 24. doi: 10.1002/ijgo.15008.
    >> Share

    June 2023
  12. MANDATO VD, Torricelli F, Mastrofilippo V, Pellegri C, et al
    Impact of 2 years of COVID-19 pandemic on ovarian cancer treatment in IRCCS-AUSL of Reggio Emilia.
    Int J Gynaecol Obstet. 2023 Jun 26. doi: 10.1002/ijgo.14937.
    >> Share

  13. LOPEZ-GONZALEZ E, Rodriguez-Jimenez A, Gomez-Salgado J, Daza-Manzano C, et al
    Role of tumor volume in endometrial cancer: An imaging analysis and prognosis significance.
    Int J Gynaecol Obstet. 2023 Jun 23. doi: 10.1002/ijgo.14954.
    >> Share

  14. BEREK JS, Matias-Guiu X, Creutzberg C, Fotopoulou C, et al
    FIGO staging of endometrial cancer: 2023.
    Int J Gynaecol Obstet. 2023 Jun 20. doi: 10.1002/ijgo.14923.
    >> Share

    May 2023
  15. EL-TAWAB SS, Kehoe S
    Synchronous ovarian and Bartholin gland carcinoma: Case report and review of literature.
    Int J Gynaecol Obstet. 2023 May 23. doi: 10.1002/ijgo.14880.
    >> Share

  16. VAN STEIN RM, Sikorska K, van der Aa MA, Sonke GS, et al
    Evaluation of external validity of the OVHIPEC-1 trial in a real-world population.
    Int J Gynaecol Obstet. 2023;161:640-648.
    >> Share

    April 2023
  17. FEGHALY I, Kourie H, Moubarak M, Chouery E, et al
    Genetic profile of borderline ovarian tumors in the Lebanese population by whole-exome sequencing.
    Int J Gynaecol Obstet. 2023 Apr 25. doi: 10.1002/ijgo.14805.
    >> Share

    February 2023
  18. AYHAN A, Tunc M, Atasoy Karakas L, Tekelioglu T, et al
    Oncologic and obstetric outcomes of early-stage epithelial ovarian cancer patients who underwent fertility-sparing surgery (a retrospective study).
    Int J Gynaecol Obstet. 2023 Feb 24. doi: 10.1002/ijgo.14732.
    >> Share

  19. FRITSCHE HA, Bullock RG
    A Reflex Testing Protocol Using Two Multivariate Index Assays Improves the Risk Assessment for Ovarian Cancer in Patients with an Adnexal Mass.
    Int J Gynaecol Obstet. 2023 Feb 23. doi: 10.1002/ijgo.14733.
    >> Share

  20. YUE X, Yue Z, Wang Y, Dong Z, et al
    Value of the Copenhagen index in the diagnosis of malignant adnexal tumors: A meta-analysis.
    Int J Gynaecol Obstet. 2023;160:506-515.
    >> Share

    January 2023
  21. XU T, Zhang L, Jiang Y, Wan Y, et al
    Clinical characteristics and serum CA19-9 combined with HE4 are valuable in diagnosing endometriosis-associated ovarian cancer.
    Int J Gynaecol Obstet. 2023 Jan 27. doi: 10.1002/ijgo.14695.
    >> Share

  22. PEEYANANJARASSRI K, Nanthamongkolkul K, Jiamset I, Chusook W, et al
    Impact of appendectomy of a grossly normal appendix on the survival outcomes of mucinous ovarian carcinomas in a tertiary hospital.
    Int J Gynaecol Obstet. 2023 Jan 23. doi: 10.1002/ijgo.14689.
    >> Share

  23. PARK CH, Kim SM, Kim SE, Lee DY, et al
    Five-year recurrence pattern of mature cystic teratoma according to operation type in young women.
    Int J Gynaecol Obstet. 2023;160:249-255.
    >> Share

    December 2022
  24. LI Q, Zhang X
    Prediction of high-risk factors for ovarian metastasis in patients with endometrial cancer: A large-sample retrospective case-control study.
    Int J Gynaecol Obstet. 2022 Dec 1. doi: 10.1002/ijgo.14606.
    >> Share

    October 2022
  25. SEABRA J, Silva A, Santos I, Almeida J, et al
    Retroperitoneal recurrence of an ovarian juvenile granulosa cell tumor: A diagnostic challenge.
    Int J Gynaecol Obstet. 2022 Oct 8. doi: 10.1002/ijgo.14496.
    >> Share

    September 2022
  26. YU H, Liang J, Liang H, Feng D, et al
    Laparoscopically assisted ovarian cystectomy with totally enclosed protective device for tumor isolation.
    Int J Gynaecol Obstet. 2022 Sep 17. doi: 10.1002/ijgo.14468.
    >> Share

    August 2022
  27. MI D, Zhang Y, Chen S
    Serum HE4 is associated with clinical prognostic factors and survival outcome in female patients with primary peritoneal carcinoma.
    Int J Gynaecol Obstet. 2022;158:352-358.
    >> Share

    June 2022
  28. CHENG CW, ElSahwi K, Borowsky ME, Aikman N, et al
    Sex Cord Stromal Tumor Presenting with Hair Loss in Postmenopausal Women.
    Int J Gynaecol Obstet. 2022 Jun 2. doi: 10.1002/ijgo.14293.
    >> Share

  29. GUNDOGDU F, Orhan N, Ozgul N, Usubutun A, et al
    Recurrent mucinous neoplasm arising in cesarean scar: A case report and review of literature.
    Int J Gynaecol Obstet. 2022;157:564-567.
    >> Share

    May 2022
  30. SAHIN EA, Toprak S, Sayal HB, Ekinci T, et al
    Analysis of prognostic factors in grade 3 endometrioid type endometrial carcinoma.
    Int J Gynaecol Obstet. 2022 May 22. doi: 10.1002/ijgo.14277.
    >> Share

  31. PERRI T, Levin G, Naor-Revel S, Eliassi-Revivo P, et al
    Risk-reducing salpingo-oophorectomy and breast cancer incidence among Jewish BRCA1/BRCA2-mutation carriers-an Israeli matched-pair study.
    Int J Gynaecol Obstet. 2022;157:431-436.
    >> Share

    March 2022
  32. AKGOR U, Ayhan A, Shushkevich A, Ozdal B, et al
    OPEC Study- An International Multicenter Study of Ovarian Preservation in Endometrial Cancers.
    Int J Gynaecol Obstet. 2022 Mar 24. doi: 10.1002/ijgo.14190.
    >> Share

    February 2022
  33. WANG L, Zhou C, Jiang J, Zhang Z, et al
    Clinicopathologic features of pregnancy luteoma.
    Int J Gynaecol Obstet. 2022 Feb 25. doi: 10.1002/ijgo.14161.
    >> Share

    January 2022
  34. BARAKE C, Atwani R, Jaafar N, Tamim H, et al
    Appropriateness of hysterectomies at the time of surgical removal of presumed benign adnexal masses.
    Int J Gynaecol Obstet. 2022 Jan 22. doi: 10.1002/ijgo.14110.
    >> Share

    November 2021
  35. TRAVAGLINO A, Raffone A, Gencarelli A, Micheli M, et al
    Dusp6 immunohistochemistry is associated with the response of atypical endometrial hyperplasia and early endometrial cancer to conservative treatment.
    Int J Gynaecol Obstet. 2021 Nov 27. doi: 10.1002/ijgo.14050.
    >> Share

    October 2021
  36. MCCLUGGAGE WG
    Progress in the pathological arena of gynecological cancers.
    Int J Gynaecol Obstet. 2021;155 Suppl 1:107-114.
    >> Share

  37. WICHMANN IA, Cuello MA
    Obesity and gynecological cancers: A toxic relationship.
    Int J Gynaecol Obstet. 2021;155 Suppl 1:123-134.
    >> Share

  38. BEREK JS, Renz M, Kehoe S, Kumar L, et al
    Cancer of the ovary, fallopian tube, and peritoneum: 2021 update.
    Int J Gynaecol Obstet. 2021;155 Suppl 1:61-85.
    >> Share

    September 2021
  39. LO HW, Weng SF, Chen HS, Tsai EM, et al
    Pelvic inflammatory disease is associated with ovarian cancer development in women with endometriosis: A cohort study in Taiwan.
    Int J Gynaecol Obstet. 2021 Sep 18. doi: 10.1002/ijgo.13935.
    >> Share

  40. TRAVAGLINO A, Raffone A, Raimondo D, Arciuolo D, et al
    Prognostic value of the TCGA molecular classification in uterine carcinosarcoma.
    Int J Gynaecol Obstet. 2021 Sep 18. doi: 10.1002/ijgo.13937.
    >> Share

  41. XU A, Nie F, Liu T, Dong T, et al
    Adnexal masses: Diagnostic performance of contrast-enhanced ultrasound (CEUS) of the simple rules from the International Ovarian Tumor Analysis group.
    Int J Gynaecol Obstet. 2021 Sep 12. doi: 10.1002/ijgo.13926.
    >> Share

    July 2021
  42. IKEDA Y, Yoshihara M, Yoshikawa N, Tamauchi S, et al
    Is cystectomy an option as conservative surgery for young patients with borderline ovarian tumor? A multi-institutional retrospective study.
    Int J Gynaecol Obstet. 2021 Jul 29. doi: 10.1002/ijgo.13844.
    >> Share

  43. MORRIS JM, Tillmanns TD, Brezina PR
    Intergenerational gestational surrogacy in a patient with ovarian dysgerminocarcinoma.
    Int J Gynaecol Obstet. 2021 Jul 13. doi: 10.1002/ijgo.13824.
    >> Share

  44. KIM SR, Maganti M, Bernardini MQ, Laframboise S, et al
    Efficacy and toxicity of intraperitoneal chemotherapy as compared to intravenous chemotherapy in the treatment of patients with advanced ovarian cancer.
    Int J Gynaecol Obstet. 2021 Jul 2. doi: 10.1002/ijgo.13813.
    >> Share

    May 2021
  45. PITARCH-MARTINEZ M, Blanco-Elena JA, Robles-Quesada MT, Alberca-Paramo A, et al
    Colonic perforation due to ovarian cancer invasion: An unusual event.
    Int J Gynaecol Obstet. 2021 May 29. doi: 10.1002/ijgo.13770.
    >> Share

  46. D'ALESSANDRO G, Frigerio M, Barra F, Costantini S, et al
    Systematic review and meta-analysis on the impact of the levonorgestrel-releasing intrauterine system in reducing risk of ovarian cancer.
    Int J Gynaecol Obstet. 2021 May 9. doi: 10.1002/ijgo.13737.
    >> Share

    April 2021
  47. DAHIYA A, Thomas V
    Response: Endometriosis and malignancy-The intriguing relationship.
    Int J Gynaecol Obstet. 2021 Apr 13. doi: 10.1002/ijgo.13688.
    >> Share

    January 2021
  48. CHEN Q, Wang S, Lang JH
    The impact of lymph node dissection on apparent stage I epithelial ovarian carcinoma: A population-based study.
    Int J Gynaecol Obstet. 2021 Jan 28. doi: 10.1002/ijgo.13627.
    >> Share

  49. DAHIYA A, Sebastian A, Thomas A, George R, et al
    Endometriosis and malignancy: The intriguing relationship.
    Int J Gynaecol Obstet. 2021 Jan 8. doi: 10.1002/ijgo.13585.
    >> Share

    December 2020
  50. LI S, Li H, Tian S, Wu J, et al
    Association between ovarian and breast masses among Chinese women in Chongqing based on ultrasonography screening: A cross-sectional study.
    Int J Gynaecol Obstet. 2020 Dec 23. doi: 10.1002/ijgo.13568.
    >> Share

  51. KIM SR, Kotsopoulos J, Sun P, Bernardini M, et al
    The impacts of neoadjuvant chemotherapy and of cytoreductive surgery on ten-year survival from advanced ovarian cancer.
    Int J Gynaecol Obstet. 2020 Dec 16. doi: 10.1002/ijgo.13542.
    >> Share

    November 2020
  52. TAKEDA T, Hayashi S, Kobayashi Y, Tsuji K, et al
    Evaluation of preoperative prediction of intestinal invasion in patients with ovarian cancer.
    Int J Gynaecol Obstet. 2020 Nov 22. doi: 10.1002/ijgo.13492.
    >> Share

  53. PERGIALIOTIS V, Papoutsi E, Androutsou A, Tzortzis AS, et al
    Galectins-1,-3,-7,-8 and -9 as prognostic markers for survival in epithelial ovarian cancer: A systematic review and meta-analysis.
    Int J Gynaecol Obstet. 2020 Nov 6. doi: 10.1002/ijgo.13471.
    >> Share

  54. ESPIAU ROMERA A, Coronado Martin PJ, Choliz Ezquerro M, Cuesta Guardiola T, et al
    Value of preoperative HE4 as predictor of advanced disease in endometrioid endometrial cancer.
    Int J Gynaecol Obstet. 2020 Nov 6. doi: 10.1002/ijgo.13473.
    >> Share

    October 2020
  55. TOPRAK S, Sahin EA, Sahin H, Tohma YA, et al
    Risk factors for cervical stromal involvement in endometrioid-type endometrial cancer.
    Int J Gynaecol Obstet. 2020 Oct 28. doi: 10.1002/ijgo.13449.
    >> Share

  56. AYHAN A, Akilli H
    Prognostic factors associated with cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy in recurrent ovarian cancer.
    Int J Gynaecol Obstet. 2020 Oct 6. doi: 10.1002/ijgo.13410.
    >> Share

    July 2020
  57. BULDUKOGLU OC, Turker A, Usubutun A, Salman MC, et al
    Relationship of lymph node status with survival and recurrence among women with endometrial cancer.
    Int J Gynaecol Obstet. 2020 Jul 17. doi: 10.1002/ijgo.13309.
    >> Share

    June 2020
  58. RODRIGUEZ J, Fletcher A, Heredia F, Fernandez R, et al
    Alternative management for gynecological cancer care during the COVID-2019 pandemic: A Latin American survey.
    Int J Gynaecol Obstet. 2020 Jun 11. doi: 10.1002/ijgo.13272.
    >> Share

  59. KHADRAOUI W, Tierney C, Chung S, Mutlu L, et al
    Risk-stratifying clinicopathologic criteria for ovarian preservation in premenopausal women with early stage low-risk endometrial cancer.
    Int J Gynaecol Obstet. 2020 Jun 7. doi: 10.1002/ijgo.13254.
    >> Share

    May 2020
  60. YOSHIHARA M, Kajiyama H, Tamauchi S, Iyoshi S, et al
    Impact of uterus-preserving surgery on Stage I primary mucinous epithelial ovarian carcinoma: A multi-institutional study with propensity score-weighted analysis.
    Int J Gynaecol Obstet. 2020 May 29. doi: 10.1002/ijgo.13244.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016